Clustering of metabolic factors and coronary heart disease

Archives of Internal Medicine

Volumn 159, Issue 10, 1999, Pages 1104-1109

  Wilson, Peter W F ^a,d   Kannel, William B ^b   Silbershatz, Halit ^c   D'Agostino, Ralph B ^c  

^a FRAMINGHAM HEART STUDY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Boston University   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CORONARY RISK; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CORONARY DISEASE; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES;

EID: 0033599981     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.10.1104     Document Type: Article

References (36)

1. The Expert Panel, National Cholesterol Education Program. Second Report: The Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1333-1445.
2. Joint National Committee. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
3. Genest J Jr, Conn JS. Clustering of cardiovascular risk factors: targeting high-risk individuals. Am J Cardiol. 1995;76:8A-20A.
4. Gumbiner B, Andresen EM, Hearne FT, et al. Metabolic risk factors for cardiovascular disease in a working population: a retrospective cohort study. J Clin Epidemiol. 1996;49:267-271.
5. Lipid Research Clinics Program. Manual of Laboratory Operation. Bethesda, Md: National Institutes of Health: 1974. NIH publication 75-628.
6. McNamara JR, Schaefer EJ. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. Clin Chim Acta. 1987;166:1-8.
7. Snedecor GW, Cochran WG. Statistical Methods. 6th ed. Ames: Iowa State University; 1967.
8. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol. 1979;110:281-290.
9. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci. 1963;107:539-556.
10. Kannel WB, Wolf PA, Garrison RJ. Section 34: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study, 30-Year Followup. Springfield, III: National Technical Information Service; 1987:1.
11. Neter J, Wasserman W. Multiple regression. Applied Linear Statistical Models. Homewood, III: Irwin; 1974:214-272.
12. Cox DR. Regression models and life tables. J R Stat Soc (B). 1972;34:187-220.
13. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York, NY: Oxford Press; 1989.
14. Raitakari OT, Porkka KV, Rasanen L, Ronnemaa T, Viikari JS. Clustering and six year cluster-tracking of serum total cholesterol, HDL-chclesterol and diastolic blood pressure in children and young adults: the Cardiovascular Risk in Young Finns Study. J Clin Epidemiol. 1994;47:1085-1093.
15. Yusuf HR, Giles WH, Croft JB, Anda RF, Casper ML. Impact of multiple risk factor profiles on determining cardiovascular disease risk. Prev Med. 1998;27:1-9.
16. Lamarche B, Despres JP, Pouliot MC, et al. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb. 1993;13:33-40.
17. Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Artheriosclerosis. 1990;10:223-231.
18. Raitakari OT, Porkka KV, Ronnemaa T, et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescents: the Cardiovascular Risk in Young Finns Study. Diabetologia. 1995;38:1042-1050.
19. Stern MP. Diabetes and cardiovascular disease: the "common soil" hypothesis. Diabetes. 1996;44:369-374.
20. Mykkanen L, Haffner SM, Ronnemaa T, Bergman RN, Laakso M. Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. Am J Epidemiol. 1997;146:315-321.
21. Liese AD, Mayer-Davis EJ, Tyroler HA, et al. Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR. Ann Epidemiol. 1997;7:407-416.
22. Kannel WB, Wilson PW. An update on coronary risk factors. Med Clin North Am. 1995;79:951-971.
23. Kannel WB. Potency of vascular risk factors as the basis for antihypertensive therapy. Eur Heart J. 1992;13(suppl G):34-42.
24. Kannel WB. Implications of Framingham Study data for treatment of hypertension: impact of other risk factors. In: Laragh JH, Buhler FR, Seldin DW, eds. Frontiers in Hypertension Research. New York, NY: Springer-Verlag; 1981:17-21.
25. Despres JP. Abdominal obesity as an important component of insulin-resistance syndrome. Nutrition. 1993;9:452-459.
26. Blomhoff JP. Lipoproteins, lipases, and the metabolic cardiovascular syndrome. J Cardiovasc Pharmacol. 1992;20(suppl 8):S22-S25.
27. Campos H, Blijlevens E, McNamara JR, et al. LDL particle size distribution: results from the Framingham Offspring Study. Arterioscler Thromb. 1992;12: 1410-1419.
28. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-888.
29. Reaven GM, Chen YD. Insulin resistance, its consequences, and coronary heart disease: must we choose one culprit? Circulation. 1996;93:1780-1783.
30. Anderson RL, Hamman RF, Savage PJ, et al. Exploration of simple insulin sensitivity measurements derived from frequently sampled intravenous glucose tolerance (FSIGT) tests: the Insulin Resistance Atherosclerosis Study. Am J Epidemiol. 1995;142:724-732.
31. Julius S, Gudbrandsson T, Jamerson K, Andersson O. The interconnection between sympathics, microcirculation, and insulin resistance in hypertension. Blood Press. 1992;1:9-19.
32. Reaven GM. Syndrome X: 6 years later. J Intern Med Suppl. 1994;736:13-22.
33. Despres JP, Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol. 1994;5:274-289.
34. Anderson KM, Wilson PWF, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample: the Framingham Offspring Study. Atherosclerosis. 1987;68:59-66.
35. Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med. 1991;325:461-466.
36. Van Gaal LF, Wauters MA, De Leeuw IH. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord. 1997;21 (suppl 1):S5-S9.